---
figid: PMC7158891__fimmu-11-00604-g0003
figlink: pmc/articles/PMC7158891/figure/F3/
number: F3
caption: An integrated overview of the immunosuppressive signaling pathways involved
  in the interaction between exosomal PD-L1 and T cells. Tumor-derived exosomal PD-L1
  can bind to PD-1 on T cells to inhibit T cell activation and cytotoxicity. Interactions
  between PD-L1 and PD-1 can induce phosphorylation of the cytoplasmic immunoreceptor
  tyrosine based inhibitory motif (ITIM) and the immunoreceptor tyrosine based switch
  motif (ITSM). The phosphorylated ITIM and ITSM recruit the SHP-1 and SHP-2 protein
  tyrosine phosphatases to attenuate activating signals of T cells. Exosomal PD-L1
  blocks TCR-mediated T cell activation. Exosomal PD-L1 can deliver inhibitory signals
  to activate T cells by downregulating CD69, CD28, and CD80 expression on the surface
  of T cells. Exosomal PD-L1 inhibits CD3/CD28-triggered T cell activation signaling
  pathways, including CD3/CD28-induced ERK phosphorylation and NF-κB activation. Exosomal
  PD-L1 inhibits the proliferation, cytokine production and cytotoxicity of CD8+ T
  cells by inhibiting the expression of granzyme B (GzmB) and inhibiting the production
  of interleukin-2 (IL-2) and tumor necrosis factor (TNF). GzmB is the effector molecule
  of cytotoxic activity in T cells, and IL-2 and TNF can enhance cytotoxic T lymphocyte
  (CTL) activation and survival via the JAK1/JAK3-STAT5 pathway. Exosomal PD-L1 may
  also affect immunosuppression through other unknown mechanisms, which are worth
  further study.
pmcid: PMC7158891
papertitle: The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in
  Cancer.
reftext: Yanyan Tang, et al. Front Immunol. 2020;11:604.
pmc_ranked_result_index: '63373'
pathway_score: 0.912252
filename: fimmu-11-00604-g0003.jpg
figtitle: An integrated overview of the immunosuppressive signaling pathways involved
  in the interaction between exosomal PD-L1 and T cells
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7158891__fimmu-11-00604-g0003.html
  '@type': Dataset
  description: An integrated overview of the immunosuppressive signaling pathways
    involved in the interaction between exosomal PD-L1 and T cells. Tumor-derived
    exosomal PD-L1 can bind to PD-1 on T cells to inhibit T cell activation and cytotoxicity.
    Interactions between PD-L1 and PD-1 can induce phosphorylation of the cytoplasmic
    immunoreceptor tyrosine based inhibitory motif (ITIM) and the immunoreceptor tyrosine
    based switch motif (ITSM). The phosphorylated ITIM and ITSM recruit the SHP-1
    and SHP-2 protein tyrosine phosphatases to attenuate activating signals of T cells.
    Exosomal PD-L1 blocks TCR-mediated T cell activation. Exosomal PD-L1 can deliver
    inhibitory signals to activate T cells by downregulating CD69, CD28, and CD80
    expression on the surface of T cells. Exosomal PD-L1 inhibits CD3/CD28-triggered
    T cell activation signaling pathways, including CD3/CD28-induced ERK phosphorylation
    and NF-κB activation. Exosomal PD-L1 inhibits the proliferation, cytokine production
    and cytotoxicity of CD8+ T cells by inhibiting the expression of granzyme B (GzmB)
    and inhibiting the production of interleukin-2 (IL-2) and tumor necrosis factor
    (TNF). GzmB is the effector molecule of cytotoxic activity in T cells, and IL-2
    and TNF can enhance cytotoxic T lymphocyte (CTL) activation and survival via the
    JAK1/JAK3-STAT5 pathway. Exosomal PD-L1 may also affect immunosuppression through
    other unknown mechanisms, which are worth further study.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD28
  - CD274
  - CD69
  - CD80
  - CD8A
  - CD8B
  - TRA
  - TRB
  - TRD
  - TRG
  - IL2
  - TNF
  - PDCD1
  - CD3E
  - CD3D
  - CD3G
  - CD247
  - IL2RA
  - GZMB
  - LCK
  - PTPN11
  - PTPN6
  - ZAP70
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - STAT5A
  - STAT5B
  - HRAS
  - KRAS
  - NRAS
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - FOSL1
  - JUND
  - TCR
  - TAM
  - 'Cytotoxic '
genes:
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: CD69
  symbol: CD69
  source: hgnc_symbol
  hgnc_symbol: CD69
  entrez: '969'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: CD8
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD8
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3E
  entrez: '916'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3D
  entrez: '915'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD3G
  entrez: '917'
- word: CD3
  symbol: CD3
  source: bioentities_symbol
  hgnc_symbol: CD247
  entrez: '919'
- word: IL-2R
  symbol: IL2R
  source: hgnc_prev_symbol
  hgnc_symbol: IL2RA
  entrez: '3559'
- word: GzmB
  symbol: GZMB
  source: hgnc_symbol
  hgnc_symbol: GZMB
  entrez: '3002'
- word: LCK
  symbol: LCK
  source: hgnc_symbol
  hgnc_symbol: LCK
  entrez: '3932'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: SHP1/2
  symbol: SHP2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: SHP1/2
  symbol: SHP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: GzmB
  symbol: GZMB
  source: hgnc_symbol
  hgnc_symbol: GZMB
  entrez: '3002'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
- word: TAM
  source: MESH
  identifier: C419191
diseases:
- word: 'Cytotoxic '
  source: MESH
  identifier: D064420
figid_alias: PMC7158891__F3
redirect_from: /figures/PMC7158891__F3
figtype: Figure
---
